Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Total revenues	$ 948,911	$ 824,268
Cost of revenues	(550,822)	(728,640)
Gross profit	398,089	95,628
Operating expenses:
Research and development	7,944,089	8,185,850
General and administrative	6,692,904	5,008,738
Total operating expenses	14,636,993	13,194,588
Loss from operations	(14,238,904)	(13,098,960)
Other income (expense):
Gain on forgiveness of PPP loan		421,584
Foreign currency transaction loss	(30,549)	(39,361)
Interest expense, net	(822,611)	(904,502)
Research and development incentives	132,869	174,770
Other income	5,921	30,754
Total other income (expense)	(714,370)	(316,755)
Net loss before income taxes	(14,953,274)	(13,415,715)
Income tax benefit	1,154,935	864,742
Net loss applicable to common stockholders	$ (13,798,339)	$ (12,550,973)
Basic net loss per share (in Dollars per share)	$ (4.81)	$ (4.69)
Diluted net loss per share (in Dollars per share)	$ (4.81)	$ (4.69)
Basic weighted average common shares outstanding (in Shares)	2,871,345	2,675,488
Diluted weighted average common shares outstanding (in Shares)	2,871,345	2,675,488
Licensing revenue
Total revenues	$ 250,000
Contract revenue
Total revenues		$ 33,351
Grant revenue
Total revenues	$ 698,911	$ 790,917